Wednesday, January 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

by Global Biodefense Staff
May 5, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

Photo credit: Brian Brooks

The National Institutes of Health (NIH) is supporting administrative supplement applications for funding from eligible investigators at National Institute of Allergy and Infectious Diseases (NIAID) Regional Biocontainment Laboratories (RBL) focused on efforts to prevent, prepare for, and respond to infectious disease outbreaks.

Active G20 Grants awarded under RFA-AI-21-022 Limited Competition: Facility and Building System Upgrades Support for the Regional Biocontainment Laboratories may request for Biosafety Level 3 (BSL-3) renovations and facilities upgrades or purchase of equipment for BSL-3.

RBL-Affiliated Research Projects: Applicants with active NIAID or NIH research grants that require a BSL-3 Biocontainment Facility and whose research projects are affiliated with one of the RBL sites for purposes of performance, whether the investigator is based at the RBL or another institution.

Example topics of interest include:

  • Research projects requiring use of the RBL and related to the development and testing of new antiviral compounds or other therapeutics, new vaccines, and point of care diagnostics tests.
  • Research projects requiring use of the RBL on other prophylactic methods to prevent infections.
  • Training new researchers in BSL-3 practices.

The proposed supplemental activities must be allowed within the original scope of the parent award. Construction activities will not be supported.

Notice of Special Interest (NOSI): Administrative Supplements for NIAID Regional Biocontainment Laboratories (RBL) and other NIH Grantees Conducting Research at RBL-affiliated Sites. Notice Number: NOT-AI-22-049. First Available Due Date: May 31, 2022. Expiration Date: 1 June 2022.

Tags: BiosafetyBSL-3BSL-4Editor PickOpportunities

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Pursues Advanced Threat-Detection for Crop Defense
Biosecurity

DARPA Pursues Advanced Threat-Detection for Crop Defense

January 3, 2023
New Framework for Livestock Disease Indemnity Valuation Proposed by USDA
Biosecurity

New Framework for Livestock Disease Indemnity Valuation Proposed by USDA

September 10, 2022
Waterfowl on a seashore
Biosecurity

HPAI Concerns Prompt U.S. Restrictions on Hunter Harvested Wild Bird Game Meat from Canada

September 2, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC